i’SUPPLY, an Egypt-based B2B healthtech company, has raised a pre-Series A funding round to support its expansion plans, strengthen its ability to finance small and medium-sized pharmacies, and improve its fintech and technological offerings. The funding round was led by Disruptech Ventures, with participation from OneStop Capital, Axian Investment CVC, Egypt Ventures, and other investors.

Strategic Growth and Expansion

Founded in 2022 by Ibrahim Emam, Malek Sultan, and Moustafa Zaki, i’SUPPLY aims to digitize the pharmaceutical industry by optimizing supply and demand transactions among drug manufacturers, distributors, wholesalers, and pharmacies. This new investment will accelerate the company’s growth strategy and enhance its ability to support small and medium-sized pharmacies. The company plans to obtain a license from the Egyptian Financial Regulatory Authority to better meet the financing needs of these pharmacies.

Impressive Milestones

i’SUPPLY has generated an annual transaction volume of EGP 1 billion ($20.9 million) and processed over one million purchase orders. Its network serves over 10,000 pharmacies and collaborates with more than 200 distribution companies, offering a portfolio of over 10,000 pharmaceuticals. This funding comes nearly two years after i’SUPPLY raised $1.5 million in a pre-seed round, also led by Disruptech Ventures.

Industry Impact and Future Prospects

The latest funding round is poised to significantly impact the Egyptian pharmaceutical industry, which is projected to generate $1.45 million in revenue in 2024, with a compound annual growth rate (CAGR) of 7.68% from 2024 to 2028, reaching a market volume of $1,948 million by 2028. The growth of i’SUPPLY aligns with this positive industry outlook, positioning the company for substantial expansion and influence in the coming years.

Enhancing Technological and Financial Solutions

i’SUPPLY’s approach focuses on leveraging technology to streamline operations and improve the efficiency of the pharmaceutical supply chain. By digitizing transactions and enhancing financial services, i’SUPPLY aims to provide better support for pharmacies, ensuring they have the resources needed to meet market demands. This focus on fintech and technological improvements will enable i’SUPPLY to offer innovative solutions that address the unique challenges faced by pharmacies in Egypt.

Broader Implications for the Healthcare Sector

The success of i’SUPPLY reflects a broader trend towards digital transformation within the healthcare sector. By providing a robust platform that connects various stakeholders in the pharmaceutical industry, i’SUPPLY is contributing to the modernization and efficiency of healthcare services in Egypt. This transformation is crucial for meeting the evolving needs of the population and ensuring that healthcare providers can deliver high-quality services.

Conclusion

i’SUPPLY’s recent pre-Series A funding round marks a significant milestone in the company’s journey towards revolutionizing the pharmaceutical industry in Egypt. With strong backing from prominent investors and a clear vision for growth, i’SUPPLY is well-positioned to make a lasting impact on the healthcare sector. As the company continues to expand its network and enhance its technological and financial offerings, it will play a vital role in supporting small and medium-sized pharmacies and driving sustainable growth in the industry.